Brief: Poseida Therapeutics To Present Interim Results From Phase 1 Trial Of P-Psma-101 At Asco Genitourinary Cancers Symposium

Poseida Therapeutics

17/02/2022 13:18

Feb 17 (Reuters) - Poseida Therapeutics Inc  PSTX.O :
    * POSEIDA THERAPEUTICS TO PRESENT INTERIM RESULTS FROM PHASE
1
TRIAL OF P-PSMA-101 AT ASCO GENITOURINARY CANCERS SYMPOSIUM

Source text for Eikon:  ID:nPn1rWFs8a 
Further company coverage:  PSTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))